Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder

Treatment of Severe, Treatment-Refractory Obsessive-Compulsive Disorder: A Study of Inpatient and Community Treatment

(2016) Mark J. Boschen et al.   CNS SPECTRUMS

Effectiveness of Long-Term Augmentation with Citalopram to Clomipramine in Treatment-Resistant OCD Patients

(2016) Donatella Marazziti et al.   CNS SPECTRUMS

New Pharmacotherapeutic Approaches to Obsessive-Compulsive Disorder

(2016) Martijn Figee et al.   CNS SPECTRUMS

Treatment strategies for obsessive-compulsive disorder

(2010) Donatella Marazziti et al.   EXPERT OPINION ON PHARMACOTHERAPY

A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder

(2010) S. Evelyn Stewart et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Current trends in drug treatment of obsessive–compulsive disorder

(2010) Eric Decloedt et al.   Neuropsychiatric Disease and Treatment

Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder

(2009) Stefano Pallanti et al.   CNS DRUGS

High-dose escitalopram for the treatment of obsessive–compulsive disorder

(2009) Ilan Rabinowitz et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a 12-week open-label preliminary study

(2009) Enrico Pessina et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Quetiapine Augments the Effect of Citalopram in Non-Refractory Obsessive-Compulsive Disorder

(2009) Nienke C. C. Vulink et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Long-Term Trial of the Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder

(2009) Hisato Matsunaga et al.   JOURNAL OF CLINICAL PSYCHIATRY

Double-Blind Study of Dextroamphetamine Versus Caffeine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder

(2009) Lorrin M. Koran et al.   JOURNAL OF CLINICAL PSYCHIATRY

Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder

(2009) Elias Aboujaoude et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Depression, anxiety and obsessive-compulsive symptoms and quality of life in children with attention-deficit hyperactivity disorder (ADHD) during three-month methylphenidate treatment

(2009) Kağan Gürkan et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial

(2009) JB Diniz et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Obsessive-compulsive disorder

(2009) Jonathan S Abramowitz et al.   LANCET

Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study

(2008) Revital Amiaz et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Escitalopram in the treatment of obsessive–compulsive disorder

(2008) Joseph Zohar   Expert Review of Neurotherapeutics

Quality of life in obsessive-compulsive disorder: an evaluation of impairment and a preliminary analysis of the ameliorating effects of treatment

(2007) Melissa M. Norberg et al.   DEPRESSION AND ANXIETY